布美他尼-D5
|
R140780-5mg
|
≥98% |
1216739-35-3 |
5mg
|
¥ 9489.0
|
5~7个工作日 |
罗恩 |
恩诺沙星-D5
|
R169904-5mg
|
99 atom % D, CP:98% |
1173021-92-5 |
5mg
|
¥ 889.0
|
5~7个工作日 |
罗恩 |
瑞德西韦-D5
|
R658643-5mg
|
≥98%,≥98atom%D |
N/A |
5mg
|
¥ 16500.9
|
期货,请咨询 |
阿拉丁 |
D-氨基葡萄糖酸
|
S161334-1g
|
≥98% |
3646-68-2 |
1g
|
¥ 1449.9
|
现货 |
阿拉丁 |
利奈唑胺 d3
|
L646472-5mg
|
≥99%,≥98atom%D |
1127120-38-0 |
5mg
|
¥ 6999.9
|
期货,请咨询 |
阿拉丁 |
a-D-五乙酰半乳糖
|
A589074-25g
|
≥95% |
4163-59-1 |
25g
|
¥ 247.9
|
现货 |
阿拉丁 |
瑞德西韦-D5
|
R658643-1mg
|
≥98%,≥98atom%D |
N/A |
1mg
|
¥ 5299.9
|
现货 |
阿拉丁 |
瑞替加滨-D4
|
R757998-1mg
|
|
N/A |
1mg
|
¥ 4999.9
|
期货,请咨询 |
阿拉丁 |
羟利培酮-D4
|
P757620-1mg
|
|
1020719-55-4 |
1mg
|
¥ 5599.9
|
期货,请咨询 |
阿拉丁 |
D-阿拉伯糖
|
161450250
|
|
28697-53-2 |
25GR
|
¥ 663.0
|
现货 |
Acros |
双丙酮-D-甘露糖醇
|
D707094-25g
|
≥92% |
1707-77-3 |
25g
|
¥ 69.9
|
期货,请咨询 |
阿拉丁 |
左乙拉西坦-d3
|
L345278-1mg
|
≥95 atom% D,≥98% |
1217851-16-5 |
1mg
|
¥ 4999.9
|
期货,请咨询 |
阿拉丁 |
D-阿拉伯糖
|
C16145-25g
|
|
28697-53-2 |
25g
|
¥ 780.0
|
现货 |
Acros |
伊达拉奉-D5
|
E757791-1mg
|
|
1228765-67-0 |
1mg
|
¥ 2999.9
|
期货,请咨询 |
阿拉丁 |
5-氯-10,11-二氢-5H-二苯并[a,d]环庚烷
|
R099138-5g
|
97+% |
1210-33-9 |
5g
|
¥ 279.0
|
现货 |
罗恩 |
5-氯-10,11-二氢-5H-二苯并[a,d]环庚烷
|
R099138-1g
|
97+% |
1210-33-9 |
1g
|
¥ 70.0
|
现货 |
罗恩 |
5-氯-10,11-二氢-5H-二苯并[a,d]环庚烷
|
R099138-25g
|
97+% |
1210-33-9 |
25g
|
¥ 752.0
|
现货 |
罗恩 |
7-[[[[(氰基甲基)硫代]乙酰基]氨基]-7-甲氧基头孢烷酸
|
C331764-10mg
|
|
56796-16-8 |
10mg
|
¥ 2092.9
|
期货,请咨询 |
阿拉丁 |
氯仿-d, for NMR, 99.8% D, 含稳定剂银箔, 1 v/v% TMS
|
368985000
|
|
865-49-6 |
500ML
|
¥ 3846.0
|
现货 |
Acros |
氯仿-d, for NMR, 99.8% D, 含稳定剂银箔, 1 v/v% TMS
|
368981000
|
|
865-49-6 |
100ML
|
¥ 903.0
|
现货 |
Acros |
氯仿-d, for NMR, 99.8% D, 含稳定剂银箔, 1 v/v% TMS
|
C36898-500ML
|
|
865-49-6 |
500ML
|
¥ 4525.0
|
现货 |
Acros |
氯仿-d, for NMR, 99.8% D, 含稳定剂银箔, 1 v/v% TMS
|
C36898-100ML
|
|
865-49-6 |
100ML
|
¥ 1062.0
|
现货 |
Acros |
Nα-Fmoc-Nomega-(2,2,5,7,8-五甲基苯并吡喃-6-磺酰基)-D-精氨酸五氟苯基酯
|
N349892-1g
|
|
200188-07-4 |
1g
|
¥ 2155.9
|
期货,请咨询 |
阿拉丁 |
Nα-Fmoc-Nomega-(2,2,5,7,8-五甲基苯并吡喃-6-磺酰基)-D-精氨酸五氟苯基酯
|
N349892-5g
|
|
200188-07-4 |
5g
|
¥ 8556.9
|
期货,请咨询 |
阿拉丁 |